Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs

Jose M VilarInstituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, Las Palmas, SpainCorrespondence[email protected]

Elena DamiáDepartment of Animal Medicine and Surgery, CEU Cardenal Herrera University, Valencia, Spain

Mónica RubioDepartment of Animal Medicine and Surgery, CEU Cardenal Herrera University, Valencia, Spain

Angelo SantanaDepartment of Mathematics, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain

Joaquin SopenaDepartment of Animal Medicine and Surgery, CEU Cardenal Herrera University, Valencia, Spain

Joaquin CeronDepartamento de Medicina y cirugía animal, Universidad de Murcia, Murcia, Spain

Asta TvarijonaviciuteDepartamento de Medicina y cirugía animal, Universidad de Murcia, Murcia, Spain

Ramón CugatArtroscopia Garcia Cugat. Plaça Alfonso Comín, Barcelona, Spain

Jose Maria CarrilloDepartment of Animal Medicine and Surgery, CEU Cardenal Herrera University, Valencia, Spain

show all

Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date